Philadelphia Pharmaceuticals Company (ASE:PHIL)

Jordan · Delayed Price · Currency is JOD

2.150

0.00 (0.00%)

At close: Nov 5, 2026

Market Cap	16.13M +38.7%
Revenue (ttm)	9.37M +2.8%
Net Income	1.07M +16.8%
EPS	0.14 +16.8%
Shares Out	7.50M
PE Ratio	15.11
Forward PE	n/a
Dividend	0.07 (3.26%)
Ex-Dividend Date	Mar 30, 2026

Volume	200
Open	2.150
Previous Close	n/a
Day's Range	2.150 - 2.150
52-Week Range	1.500 - 2.150
Beta	-0.08
Analysts	n/a
Price Target	n/a
Est. Earnings	Feb 4, 2027

About ASE:PHIL

Philadelphia Pharmaceuticals Company develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan. The company provides products for skin related disorders, including anti-lice and scabicides preparations, antiseptics and disinfectants, bleaching and hyperpigmentation disorders preparations, emollients and protectives, keratolytics/topical psoriasis treatment preparations, and skin healing agents, as well as agents for dermatitis; and topical acne preparation, anti... [Read more]

Industry Pharmaceutical Preparations

Founded 1993

Employees 129

Stock Exchange Amman Stock Exchange

Ticker Symbol PHIL

Full Company Profile

Financial Performance

In 2025, ASE:PHIL's revenue was 9.17 million, an increase of 4.64% compared to the previous year's 8.76 million. Earnings were 1.01 million, an increase of 22.35%.

Financial Statements